Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey R Dahlen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Thrombosis and Haemostasis|July 23, 2019
Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular DiseaseKoichi Kaikita, Kazuya Hosokawa, Jeffrey R Dahlen, et al.
Lancet (London, England)|March 30, 2017
ANTARCTIC: platelet function testing to adjust therapyPaul A Gurbel, Matthew J Price, Jeffrey R Dahlen, et al.
Journal of Clinical & Translational Endocrinology|May 6, 2020
Finding the clinical utility of 1,5-anhydroglucitol among primary care practitionersJohn Peabody, David Paculdo, M Czarina Acelajado, et al.
European Journal of Clinical Pharmacology|September 22, 2023
Differential inhibition of platelet function by cilostazol in combination with clopidogrelMasako Yamazaki, Yuka Shirai, Tomoko Ohnishi, et al.
Cardiorenal Medicine|January 16, 2022
Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular ProceduresJohn Peabody, David Paculdo, Czarlota Valdenor, et al.
Platelets|June 7, 2011
Modification of the VerifyNow® P2Y12 test BASE channel to accommodate high levels of P2Y(12) antagonismJoseph A Jakubowski, Chunmei Zhou, Blaine Egan, et al.
Journal of Diabetes Science and Technology|July 9, 2019
Variation in Diabetes Management: A National Assessment of Primary Care ProvidersJohn W Peabody, Enrico de Belen, Jeffrey R Dahlen, et al.
Current Problems in Cardiology|May 17, 2021
Measuring the Variation in the Prevention and Treatment of CI-AKI Among Interventional CardiologistsCzarlota Valdenor, Peter A McCullough, David Paculdo, et al.
Open Forum Infectious Diseases|July 12, 2021
First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19Udaya S Tantry, Kevin P Bliden, Alastair Cho, et al.
Clinical Chemistry|September 23, 2003
Early biomarkers of strokeMark A Reynolds, Howard J Kirchick, Jeffrey R Dahlen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Thrombosis and Haemostasis|July 23, 2019
Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular DiseaseKoichi Kaikita, Kazuya Hosokawa, Jeffrey R Dahlen, et al.
Lancet (London, England)|March 30, 2017
ANTARCTIC: platelet function testing to adjust therapyPaul A Gurbel, Matthew J Price, Jeffrey R Dahlen, et al.
Journal of Clinical & Translational Endocrinology|May 6, 2020
Finding the clinical utility of 1,5-anhydroglucitol among primary care practitionersJohn Peabody, David Paculdo, M Czarina Acelajado, et al.
European Journal of Clinical Pharmacology|September 22, 2023
Differential inhibition of platelet function by cilostazol in combination with clopidogrelMasako Yamazaki, Yuka Shirai, Tomoko Ohnishi, et al.
Cardiorenal Medicine|January 16, 2022
Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular ProceduresJohn Peabody, David Paculdo, Czarlota Valdenor, et al.
Platelets|June 7, 2011
Modification of the VerifyNow® P2Y12 test BASE channel to accommodate high levels of P2Y(12) antagonismJoseph A Jakubowski, Chunmei Zhou, Blaine Egan, et al.
Journal of Diabetes Science and Technology|July 9, 2019
Variation in Diabetes Management: A National Assessment of Primary Care ProvidersJohn W Peabody, Enrico de Belen, Jeffrey R Dahlen, et al.
Current Problems in Cardiology|May 17, 2021
Measuring the Variation in the Prevention and Treatment of CI-AKI Among Interventional CardiologistsCzarlota Valdenor, Peter A McCullough, David Paculdo, et al.
Open Forum Infectious Diseases|July 12, 2021
First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19Udaya S Tantry, Kevin P Bliden, Alastair Cho, et al.
Clinical Chemistry|September 23, 2003
Early biomarkers of strokeMark A Reynolds, Howard J Kirchick, Jeffrey R Dahlen, et al.
Pageof 2